An investigation of how the Nazis helped German tycoons make billions from the horrors of the Third Reich and World War II and how the world allowed them to get away with it. When Porsche makes its planned public debut later this year, the descendants of the sports car manufacturer’s eponymous founder an SS…
Inflation is here to stay, with rising prices and a “cost of living crisis” at the top of the economic, political, and social agenda. The central banks and monetary policy have again come under the spotlight. While the issues change, the debate over how monetary and financial stability can best be sustained abides, Twenty-First Century…
Private equity was once an investment niche, but today the wealth controlled by its leading firms surpasses the GDP of some nations. Private equity has overtaken investment banking- and well-known names like Goldman Sachs and Morgan Stanley as the premier destination for ambitious financial talent, as well as the investment dollars of some of the…
Paxlovid a Covid experimental pill developed by the US company Pfizer cuts the risk of hospitalisation or death in vulnerable adults, according to their clinical trial. Pfizer says it stopped trials early as the initial results were so positive. The UK has already ordered 250, 000 courses of the new Pfizer treatment along with another…
Competition authorities in the UK gave green light in Astra Zeneca’s $39bn takeover deal of US giant Alexion Pharmaceuticals delivering the British pharma a lucrative portfolio of immunology and a towering presence in rare diseases. Astra Zeneca on Wednesday announced the completion of its Alexion acquisition, a week after securing a pivotal nod from UK’s…
The first new treatment of Alzheimer’s disease for nearly 20 years has been approved by regulators in the United States clearing the way for its use in the UK. Aducanumab targets amyloid, a protein that forms abnormal; crumps in the brains of people with Alzheimer’s that can damage cells and trigger dementia, communication issues, memory…
Heavy Light is the story of a mental breakdown, a journey through mania, psychosis, and treatment in a psychiatric hospital, and onwards to release, recovery and healing. Heavy Light deal with a lifetime of ups and downs, from hypomania in the Alps to a complete breakdown and a locked ward in Wakefield, explaining how…
Three generations of the Sackler dynasty and their roles in the stories of the opioid Valium, and Opioid OxyContin, revealing misery, greed and pliant regulators and the abuse of philanthropy. Patrick Radden Keefe, a New Yorker writer and prize-winning, bestselling author of Say Nothing, reveals the inside story. In 1980s, a small UK drugs company…
A weekly injection of semaglutide, along with a special diet and fitness would suppress appetite and has led some people to lose more than a fifth of their body weight, according to a major international trial. The study conducted on 2, 000 people revealed an average 15kg weight loss during the 15-month trial. Scientists said…
Respected financial journalist Alex Brummer and Brexit supporter was offering an argument for optimism in his must read book The Great British Reboot, and offers a manifesto for how to re-engineer the UK economy. Brummer’s prescriptions align with Prime Minister Boris Johnson’s political prospectus, despite the gap between strategy and implementation remains wide apart. His analysis of…